Fischer Medical Ventures Limited operates in healthcare and medical-device businesses, with a focus on specialized medical products and healthcare services. Its business benefits from increasing demand for organized healthcare and advanced medical technologies. India's expanding healthcare infrastructure and rising medical expenditure provide long-term opportunities. Product development and expansion of distribution can increase market reach. Regulatory approvals, clinical requirements, product adoption, healthcare spending, and competition remain important considerations.
| Market cap | Sales (TTM) | Net profit (TTM) | P/E | EPS (TTM) | P/B | ROE | Debt / equity | Free cash flow | EV / EBITDA | Beta |
|---|---|---|---|---|---|---|---|---|---|---|
| ₹1,850 cr | — | — | 63.8 | 0.46 | 4.81 | 7.7% | 0.19 | ₹-103 cr | 36.1 | 0.61 |
| Quarter | Sales ₹ cr | Net profit ₹ cr | EPS | EPS YoY | Sales YoY | Net margin |
|---|---|---|---|---|---|---|
| Jun 2026 | 82 | 4 | 0.06 | -22.1% | +249.4% | 4.6% |
| Mar 2026 | 98 | -7 | -0.11 | — | — | -7.3% |
| Dec 2025 | 101 | 19 | 0.30 | — | — | 19.0% |
| Sep 2025 | 86 | — | — | — | — | — |
| Jun 2025 | 23 | 5 | 0.08 | — | — | 21.4% |
| Check | Result |
|---|---|
| Latest quarter EPS up 25%+ on a year ago | ✗ Fail |
| EPS growth accelerating over 3 quarters | — Not assessable |
| Sales up 25%+, or sales growth accelerating | ✓ Pass |
| Annual EPS up 25%+ in each of the last 2 years | — Not assessable |
| Net margin above the same quarter last year | ✗ Fail |
| Method | Checks | Score | Verdict |
|---|---|---|---|
| Minervini | ✗ Close above the 150- and 200-day averages ✗ 150-day above 200-day ✗ 200-day rising for a month ✗ 50-day above the 150- and 200-day ✗ Close above the 50-day ✗ At least 25% above the 52-week low · low 28.27 ✗ Within 25% of the 52-week high · high 117.71 ✗ RS percentile 70 or more · RS 0 Trend template - the gate, measured: a modest 21-day edge. | 0/8 | 0 of 8 |
| Weinstein | Stan Weinstein's stage analysis on the 30-week moving average. | Stage 4 - declining | |
| CAN SLIM | ✗ C latest quarter EPS up 25%+ — A annual EPS up 25%+ in each of the last 2 years · O'Neil asks 3; ~2 held ✗ N within 15% of the 52-week high · high 117.71 ✓ S more volume on up days than down days (50 sessions) · 1.50x ✗ L RS percentile 80 or more · RS 0 — I institutional sponsorship rising · shareholding not collected yet ✓ M market in an uptrend (40%+ of stocks above their 200-day) · breadth 45% William O'Neil's growth-leader checklist. | 2/5 | Weak |
| Darvas | ✗ New 52-week high in the last 120 sessions Darvas needs a new 52-week high to start a box. | 10/100 | No box |
| Turtle | ✗ Close above the prior 55-session high · 40.27 ✗ Close above the prior 20-session high · 36.15 ✓ Close below the prior 20-session low · 29.11 Donchian channel breakout - the Turtle traders' entry. | Breakdown | |
| Graham | ✗ Price at or below the Graham number · Graham number 7.80 ✗ P/E 15 or less · P/E 61.5 ✗ P/B 1.5 or less (or P/E x P/B 22.5 or less) · P/B 4.81 ✗ Current ratio 2 or more · 1.62 — 10 years of positive earnings, 20 of dividends · history not held Benjamin Graham's defensive-investor tests. | 28/100 | Expensive |
| Stock | 1M % | 3M % | 6M % | 1Y % | 3Y % | 5Y % | P/E | P/B | ROE % | ROCE % | ROA % | D/E | EV/EBITDA | ₹ Cr | Sales TTM ₹ Cr | Profit TTM ₹ Cr | EPS | Beta |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FISCHER this stock | -14.7 | -29.2 | -31.0 | -69.8 | — | — | 63.8 | 4.81 | 7.7 | — | — | 0.19 | 36.1 | 1,850 | — | — | 0.5 | 0.61 |
| GCSL | +18.5 | +41.1 | +107.8 | +232.3 | — | — | 47.5 | 7.18 | 19.8 | — | — | 0.04 | 41.4 | 1,770 | 194 | 40 | 15.4 | 0.38 |
| AEROFLEX | -1.1 | +24.4 | +67.9 | +198.2 | +195.5 | — | 97.9 | 14.95 | 14.1 | 19.0 | — | 0.00 | 68.7 | 6,685 | 503 | 67 | 5.2 | 1.58 |
| SPECTRUM | +21.2 | +90.7 | +217.6 | +179.9 | — | — | 100.6 | 23.68 | 20.4 | 17.7 | — | 0.90 | 72.4 | 5,788 | 680 | 58 | 36.6 | -0.04 |
| KESORAMIND | +6.7 | +9.5 | +20.1 | +141.8 | +217.1 | +301.2 | — | 1.07 | -21.5 | -10.3 | — | 0.59 | — | 396 | 325 | -108 | -3.5 | 0.98 |
| KANORICHEM | -3.1 | +21.9 | +130.6 | +124.6 | +36.1 | -3.5 | 5.0 | 1.36 | 27.6 | 6.0 | — | 0.51 | 11.7 | 779 | 1,240 | 153 | 35.5 | 1.41 |
| MANINDS | +3.9 | +65.1 | +65.1 | +122.3 | +287.1 | +712.2 | 32.0 | 3.18 | 9.2 | 16.7 | — | 0.24 | 14.5 | 6,634 | 3,875 | 204 | 27.7 | 1.96 |
| YASHO | -11.7 | +15.0 | +138.1 | +121.4 | +100.8 | — | 69.5 | 9.60 | 5.8 | 9.1 | — | 1.22 | 34.0 | 4,260 | 1,138 | 61 | 50.9 | 0.95 |
| SMARTLINK | +16.6 | +19.4 | +84.4 | +97.8 | +45.0 | +114.7 | — | 1.22 | — | — | — | — | — | — | — | — | — | 0.70 |
| MMP | +2.5 | +68.2 | +89.8 | +82.1 | +120.3 | +222.2 | 24.2 | 3.51 | 9.3 | 8.9 | — | 0.53 | 25.3 | 1,215 | 873 | 50 | 19.7 | 1.08 |
| DOLPHIN | -5.2 | +66.8 | +56.7 | +64.9 | +1168.7 | — | 35.0 | 7.14 | 25.9 | 14.9 | — | 0.57 | 31.2 | 2,523 | 143 | 72 | 18.0 | 0.47 |